SARS-CoV-2 in Mexico: Beyond Detection Methods, Scope and Limitations
The new coronavirus that was first identified in December 2019 in Wuhan China, now called SARS-CoV-2, which causes the disease called COVID-19, has spread from China to the entire world in a few months. Due to its contagious potential (R0: 5.7) and because there is still no effective treatment to st...
Main Authors: | Cynthia Martinez-Liu, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Kame Galan-Huerta, Sonia Lozano-Sepulveda, María del Carmen Martínez-Guzmán, Ana Maria Rivas-Estilla |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/1/124 |
Similar Items
-
Seroprevalence of antibodies IgG/IgM anti-T. gondii in women of Coro, Venezuela
by: Saúl-García Yotsabeth, et al.
Published: (2019-06-01) -
Resposta imune humoral na neurocisticercose
by: Suzuki, Lisandra Akemi
Published: (2010) -
High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo
by: Armel Landry Batchi-Bouyou, et al.
Published: (2021-05-01) -
Rubella seromarkers and determinants of infection among tanzanian children and adolescents in prevaccination Era: Are we in the right track?
by: Mariam M Mirambo, et al.
Published: (2017-01-01) -
The prevalence of Toxoplasma antibodies in women during marriage consultation in Gorgan
by: M.Saeedi (M.Sc), et al.
Published: (2002-03-01)